Zobrazeno 1 - 2
of 2
pro vyhledávání: ''
Autor:
Christoph Bode, Martin Moser
Publikováno v:
Der Klinikarzt. 41:16-21
Safe and effective anticoagulation is a therapeutic cornerstone of thromboembolic diseases. Until recently oral vitamin K antagonists were the standard drugs for this indication. The new oral antagonists of the coagulation factors Xa (apixaban, rivar
Autor:
Job Harenberg
Publikováno v:
Der Klinikarzt. 38:443-451
Initial clinical trials have shown that new oral anticoagulants yield at least equal or even more effective and at least equally or better tolerated results than INR-adjusted coumarins. So far, data have been published for Dabigatran for atrial fibri